The head of Arm, one of the UK's most important technology companies, says that artificial intelligence cannot currently do the detailed work needed to understand how cancer develops and spreads in people's bodies. This kind of complex analysis—studying genetic markers that tell us whether someone might get cancer—requires enormous computing power. Right now, there simply aren't enough powerful computers available to run these experiments.
However, the Arm leader expressed optimism that this problem is temporary. He believes that as more computer chips become available, AI systems will eventually be able to crack cancer's genetic code and help scientists find new cures. The message is clear: the tools exist in theory, but the hardware to power them doesn't yet.